Positive modulators of the AMPA receptor
Authors:
- 1 October 2000
- journal article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 10 (10) , 1539-1548
Abstract
Alterations in the excitatory neurotransmission by AMPA-type (α-methyl3-hydroxy-5-methyl-4-isoxazol-4-ylpropionic acid) glutamate receptors may be involved in the aetiology of neurological diseases such as Alzheimer’s disease and schizophrenia. The potentiation of AMPA-receptor mediated synaptic transmission by allosteric positive modulators of this receptor (Ampakines™) may have beneficial behavioural effects in these diseases. The development of compounds acting as Ampakines has led to CX516 (Ampalex™, Cortex Pharmaceuticals), which has reached the early stage of clinical trials for schizophrenia. The number of structural classes of compounds reported in the patent literature as positive modulators of the AMPA receptor is expanding from the earlier benzoyl piperidine (aniracetam) and thiazide (cyclothiazide, diazoxide) chemical series. This review covers the patent literature from the last five years (January 1995 to June 2000) in which there are claims for positive modulators of the AMPA receptor.Keywords
This publication has 34 references indexed in Scilit:
- Therapeutic potential of positive AMPA receptor modulators in the treatment of neurological diseaseExpert Opinion on Investigational Drugs, 2000
- 4H-1,2,4-Pyridothiadiazine 1,1-Dioxides and 2,3-Dihydro-4H-1,2,4-pyridothiadiazine 1,1-Dioxides Chemically Related to Diazoxide and Cyclothiazide as Powerful Positive Allosteric Modulators of (R/S)-2-Amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic Acid Receptors: Design, Synthesis, Pharmacology, and Structure−Activity RelationshipsJournal of Medicinal Chemistry, 1998
- Enhancement by an Ampakine of Memory Encoding in HumansExperimental Neurology, 1997
- Evidence That a Positive Modulator of AMPA-Type Glutamate Receptors Improves Delayed Recall in Aged HumansExperimental Neurology, 1997
- Enantioselective synthesis of a pyrrolo-benzothiadiazine derivative S 18986, a new AMPA receptor positive modulatorBioorganic & Medicinal Chemistry Letters, 1996
- Psychological effects of a drug that facilitates brain AMPA receptorsInternational Clinical Psychopharmacology, 1996
- Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common groundSchizophrenia Research, 1995
- Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusersBrain Research, 1995
- Selective effects of aniracetam across receptor types and forms of synaptic facilitation in hippocampusHippocampus, 1991
- Distribution of [3H]AMPA binding sites in rat brain as determined by quantitative autoradiographyBrain Research, 1984